Cramer’s Investing Club Stock Profile: Drugmaker Abbvie deserves a lot more love from the market

Posted on January 25, 2022 by Times of News

Cramer’s Investing Club: We’re adding to our position in this drugmaker on weaknessInvesting Club: We’re starting a new position in this energy name, buying more of a bankMonday, Jan. 24: Jim Cramer discusses what he’s buying in the oversold market

RELATED ARTICLES
U.S. faces unnecessary Covid deaths if Congress fails to pass funding bill, top health official warns
7 hours ago
We’re adding to a health insurance stock on the dip that had great earnings
7 hours ago
Scammers are taking advantage of a baby formula shortage, Federal Trade Commission warns
7 hours ago
Treatment with imatinib results in lower mortality rates for patients with severe COVID-19 – News
7 hours ago
Singapore reports 2 deaths, 6,442 new COVID-19 cases
7 hours ago
Tencent profit halves as crackdown, COVID-19 weigh
7 hours ago
Latest News
U.S. faces unnecessary Covid deaths if Congress fails to pass funding bill, top health official warns
7 hours ago
We’re adding to a health insurance stock on the dip that had great earnings
7 hours ago
Scammers are taking advantage of a baby formula shortage, Federal Trade Commission warns
7 hours ago
Treatment with imatinib results in lower mortality rates for patients with severe COVID-19 – News
7 hours ago
Singapore reports 2 deaths, 6,442 new COVID-19 cases
7 hours ago
Tencent profit halves as crackdown, COVID-19 weigh
7 hours ago
Coronavirus Disease (COVID-19): Weekly Epidemiological Update (18 May 2022) – World
7 hours ago
Jalukie: Efforts to amplify COVID-19 vaccination prog | MorungExpress | morungexpress.com
7 hours ago